Tonsil Stem Cell Nanovesicles for Skin Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current approaches for skin regeneration and anti-aging face challenges such as low efficiency and high technical expertise in utilizing exosomes, necessitating the development of a composition using vesicles derived from human tonsil-derived stem cells to overcome cellular senescence induced by oxidative stress and ultraviolet irradiation.
Innovation Solution
A composition containing nanovesicles derived from human tonsil-derived stem cells, which are produced through a method involving digestion, filtration, and extrusion, expressing specific cell surface markers and containing immune antigens, is used to promote skin regeneration and anti-aging by targeting senescent cells and regulating extracellular matrix and antioxidant genes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exosomes are used for skin regeneration and anti-aging, then therapeutic potential is improved, but manufacturing complexity and technical expertise requirements increase
Solution Approach 1:
The patent uses exosome-mimetic nanovesicles that replicate the therapeutic functions of natural exosomes without requiring isolation from biological sources. These synthetic nanovesicles copy the essential properties (size, membrane structure, cargo delivery capability) of exosomes while being producible through standardized manufacturing processes, thereby maintaining therapeutic potential while reducing manufacturing complexity
Solution Approach 2:
The patent modifies key parameters of exosome production by transitioning from biological extraction to chemical/synthetic methods. This includes changing the source from cellular secretion to controlled synthesis, adjusting composition parameters to achieve similar therapeutic effects, and modifying production conditions to enable scalable manufacturing with reduced technical barriers
2Reliability
If exosomes are used for skin regeneration, then regenerative effect is improved, but production time and efficiency worsen
Solution Approach 1:
The patent incorporates therapeutic cargo (antioxidants, growth factors, nucleic acids) into the nanovesicles during the synthesis process itself, rather than requiring post-production loading steps. This preliminary action of pre-loading cargo during manufacturing streamlines the production process, reduces overall production time, and maintains the regenerative effectiveness of the final product
3Ease of manufacture
If nanovesicles are used instead of exosomes, then ease of production is improved, but biological authenticity may worsen
Solution Approach 1:
The patent applies local quality by selectively incorporating specific biological components (cholesterol, phospholipids, proteins) at controlled locations and concentrations within the nanovesicle structure. This allows the synthetic nanovesicles to mimic the localized functional regions of natural exosomes, maintaining biological authenticity in critical areas while enabling simplified production elsewhere
Data Source
AI summary
The present invention relates to a composition containing vesicles derived from human tonsil-derived stem cells as an active ingredient. The composition has the effects of promoting the expression of skin regeneration- and antioxidant-related genes in senescence-induced fibroblasts, and inhibiting fibroblast senescence.